How is the stock market doing, excluding the big tech stocks? The short answer: The market outside of big tech is doing meaningfully better than the headline indexes suggest. The average stock is beating the cap-weighted market The cleanest measure of "the market ex-big-tech" is the S&P 500 Equal Weight, where each of the 500 stocks counts the same instead of being dominated by the mega-caps. Through Friday October 30, it's up +14.0% on price (+15.3% with dividends) year-to-date , versus about +11.8% total return for the regular cap-weighted S&P 500 . That gap is the direct result of tech dragging the cap-weighted index: tech is roughly 40% of the standard S&P 500 but only about 16% of the equal-weight version. October showed the split starkly Tech just had its worst month since March 2025, while the rest of the market gained: Index October return Nasdaq-100 -6.65% Nasdaq Composit...
It's Medicare "Disadvantage" time again. PLEASE IGNORE Medicare Advantage plans are frequently criticized as a bad idea because they replace the open access of Original Medicare with restrictive, managed-care networks and heavy administrative hurdles. While these private insurance plans are heavily marketed for their "$0 premiums" and extra perks like dental or vision care, critics point out that they introduce significant financial and medical risks when you actually become sick. The primary reasons consumer advocates, medical professionals, and patients consider Medicare Advantage a bad idea center on the following systematic limitations: 1. Restrictive Provider Networks Limited choices: You are confined to a specific network of local doctors and hospitals (HMOs or PPOs). Dropping providers: Insurance companies can drop doctors or entire hospital systems from their network at any time during the year. No travel ...